Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
80,721,000 not fully diluted
Here's what Bunka was talking about when he mentioned DOJ investigation of Altria.
https://www.fool.com/investing/2020/04/14/british-american-tobacco-is-under-criminal-investi.aspx
Must be utter and complete turmoil at Altria if they can't give Lexaria a decision one way or another or even communicate and ask for an extension due to the unforeseen circumstances. Bizarre to say the least and something I had not seen coming, I assumed either a yes or no, not left in limbo.
I emailed him this morning and he replied within a half hour. I complained about Lexaria non-entry into the Canadian MJ market and asked about Altria and yes I told him I was a disillusioned shareholder of 4 years.
I appreciate his honesty anyway.
At least he replied.
"I'm sorry you are disillusioned, I can certainly see why you might be. It has indeed been difficult to get a Canadian major LP involved, though with the inept management demonstrated at several of them I am not entirely surprised. Still, it is our job to get deals done and we have not progressed as much as we expected.
W/R to Altria, I hope you would agree with us that we are not allowed to make up news. We have asked ALtria repeatedly for official notice of their intentions, and they have yet to give us that. We have conferred repeatedly with our lawyers who have strongly cautioned against making it up or assuming one thing or the other, ergo we have had little choice but to remain silent. Altria seems to be in disarray with the changes in their executive suite, the DOY investigation, turmoil at JUUL and more. I just do not know what their intentions are.
If you are so frustrated then maybe for your own peace of mind you should consider not owning early stage stocks like Lexaria - these are high-risk and difficult to navigate at the best of times; and these are anything but the best of times.
Regardless, I thank you for your support in the past and wish you every success in the future. We have an awesome team here who work hard everyday, and while some of our achievements have been marvelous, we do not get everything perfectly right."
Best wishes,
Chris
With the Altria deal off the table, we can expect to see the announcement of a diluting financing soon, they must be pretty well out of cash after that last small raise.
We don't know anything for certain, like when is Lexaria going to get their act together and enter the Canadian edibles market, they completely blew that with no sign that they are any closer to doing it.
Yup, it looks like it's all over between Altria and Lexaria. Altria must have quietly walked away and Bunka is not saying anything to avoid sending the stock down into the teens.
Disappointed in this company, first they blow the legalization in Canada, it's been almost 6 months, and they still don't have any meaningful presence in the Canadian market and now this.
I can see Red Bull with DehydraTECH Nicotine or you buy the packet and add the mix-and-serve powder to your coffee or whatever beverage. Perfect for plane trips.
Grabbed another 8500, just in case, pushed the price to .415 in Canada.
Thanks for that damAcon1, I didn't know Altria reported tomorrow. Tomorrow would, of course, be a very auspicious time to announce their further expansion into the world of smokeless tobacco with their continuing investment into Lexaria and the development of Pouches, lozenges, and mix and serve nicotine beverages powders.
I'll keep my hope alive 1 more day.
Good news on remdesivir, hopefully it will be even more effective if given to patients before they're critically ill.
Deafening quiet from Lexy/Altria. Is the gig up?
7000 chemicals are created when tobacco burns many of which are clearly toxic. It's kind of like Trump's idea of injecting cleaning agents, yes it will kill the virus but also kills the host.
https://www.lung.org/quit-smoking/smoking-facts/whats-in-a-cigarette
Again, there is no information that suggests Lexaria has shifted its focus towards Lexaria Pharma and covid-19 and away from its other divisions. I believe they are pursuing opportunities for all their divisions.
Chris Bunka never said anything like this, 'And now suddenly focus is that every one will get Covid-19 antiviral shot through Dehydratech and Lexy will receive millions of Dollars for doing research on covid-19 from Health Canada'
Where's the evidence, please provide a link to back up your assertions.
Dr. to Patient. "You've got Covid-19, take 1 Remdesivir powered by DehydraTECH and call me in the morning" LOL
Thanks, Abundance. I wonder if the 3 include Altria.
Gilead, the maker of remdesivir, this year, the company placed at 139 on the Fortune 500 list with revenue of $22.1 billion.
Yeah, I know I'm dreaming again- Lexy and Gilead.
CycloLab is a small private company located in Budapest, Hungary and is involved in the fight against coronavirus via its expertise in the cyclodextrin technology and by manufacturing the critical excipient, Dexolve (sulfobutyl-ether beta-cyclodextrin, SBECD) that enables remdesivir to work. SBECD is combined with a wide range of active pharmaceutical ingredients to improve their solubility or stability.
Remdesivir, which is a broad-acting antiviral with tremendous efficacy, is practically insoluble in water, which prevents the preparation of an injectable formulation to treat patients. Once pharma companies (Gilead and numerous others globally) use the proper technology and combine the active with this particular cyclodextrin, remdesivir gets water-soluble, can exert its effect and fight the virus effectively.
https://cyclolab.hu/news/cyclolab_picks_up_the_gauntlet_to_fight_coronavirus
Yes, and everyone is certainly entitled to their opinion but I'll stick with the scientists.
Smokers are 14 times more likely to die from COVID-19
https://www.ersnet.org/covid-19-blog/covid-19--propelled-by-smoking--could-destroy-entire-nations
You're right, there's been no new attempt announced by Gilead to make it in pill form. It sounds like they tried in the past and found that infusion was the most effective means of administration. If it's a fat-soluble drug then it may be amenable for use with DehydraTECH. We know Lexaria has been looking at trying to combine the two.
It looks like Remdesivir is showing promise, now they need to develop an oral version with, we know who...
https://www.cnbc.com/2020/04/16/sp-500-etf-jumps-2percent-after-hours-on-report-gilead-drug-showing-effectiveness-treating-coronavirus.html?__source=sharebar%7Cfacebook&par=sharebar
Welcome, I believe your timing is going to be impeccable!
Yes, isn't that interesting? Just think, Philip Morris develops a covid-19 vaccine from tobacco leaves and then uses DehydraTECH to deliver it. An orally delivered vaccine for the masses. That means that they will have to invest in Lexaria Pharma as well as Lexaria Nicotine.
Yes, this is the trial that Lexaria should be a part of hopefully. As long as the drugs do not have to be administered intravenously.
Altria received the results from the NRC in the middle of January, so the 90 days should be up on April 15.
Gilead says it has no plans to turn remdesivir into a pill. “Based on our understanding of remdesivir from preclinical studies, intravenous administration allows for the most stability and appropriate levels of the drug in the blood system,” a company spokesperson tells C&EN.
https://cen.acs.org/biological-chemistry/infectious-disease/initial-remdesivir-data-tell-us/98/i13
Perhaps DehydraTECH can give them the stability and appropriate level of the drug in the bloodstream with an oral product for the masses.
Remdesivir is administered by injection. Can Remdesivir be adapted with DehydraTECH into an oral anti-viral drug that can be administered to millions? I assume the reason that Remdesivir is administered by IV is because of poor oral bioavailability?
Thanks for those links Abundance. Approval for the trials using DehydraTECH should come quickly, we have extensive safety data from the prestigious NRC of Canada and we also have as advisor, Dr. Ainslie is Co-Director for the Centre for Heart, Lung and Vascular Health, Canada, Research Chair in Cerebrovascular Physiology and Professor, School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia, Okanagan Campus.
I see we acquired a new advisor, but what happened to those other doctors who were scientific advisors.
Jamieson Bondarenko, CFA, CMT Capital Markets Advisor
• Capital Markets Advisor to MustGrow Biologics
• Chairman of BriaCell Therapeutics
• Previous Equity Capital Markets roles with Eight Capital, Dundee Securities, HSBC
They're not saying yet. I suspect the Canadian university will be UBC and perhaps one of the labs they will be working with will be the U.S. Army Medical Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland. Stay tuned for further developments.
Nice, all we need is for the clinical study to confirm that DehydraTECH can deliver over 300% more retroviral drug into the bloodstream than the control of only 15% and then all hell should break loose. How many diseases or conditions can benefit from more efficient drug delivery? Many for sure.
Hopefully, he has a mild case and can still work from home
Must have been someone trying to spoof the market!
Looks like we're heading for a year high on volume, one more number to go.
They're moving straight to human trials with drugs that are already approved so this could be a quick process. "As an initial step in the research program, Lexaria intends to conduct a pilot human pharmacokinetic exploratory study in healthy volunteers of three anti-retroviral drugs that have previously been studied against other coronavirus strains,..."
NO, no ,no. Shhh! Let's make this our little secret.